NEW YORK (GenomeWeb) – Nanion Technologies and Axion Biosystems today announced a distribution deal covering Europe and China.

Under the terms of the agreement, Nanion will immediately distribute, service, and support Axion's single-well microelectrode array system called the Muse, as well as the Maestro system, a multiwall MEA system with high-throughput screening capabilities. The deal comes amid growing demand for "disease-in-a-dish" assays and functional safety screening, the companies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.

In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.

The term 'epigenetics' is being used by quacks to give them a veneer of science, writes Adam Rutherford at the Observer.

The NIH has issued a preliminary guidance for newborn dried blood spot research.